Invention Grant
- Patent Title: NKp46 binding proteins
-
Application No.: US15321650Application Date: 2015-06-23
-
Publication No.: US10519234B2Publication Date: 2019-12-31
- Inventor: Laurent Gauthier , Nadia Anceriz , Ariane Morel , Benjamin Rossi
- Applicant: INNATE PHARMA
- Applicant Address: FR Marseilles
- Assignee: INNATE PHARMA
- Current Assignee: INNATE PHARMA
- Current Assignee Address: FR Marseilles
- Agency: Baker, Donelson, Bearman, Caldwell & Berkowitz PC
- Agent Robin L. Teskin
- International Application: PCT/EP2015/064063 WO 20150623
- International Announcement: WO2015/197593 WO 20151230
- Main IPC: C07K16/28
- IPC: C07K16/28

Abstract:
Multispecific proteins that bind and specifically redirect NK cells to lyse a target cell of interest are provided without non-specific activation of NK cells in absence of target cells. The proteins have utility in the treatment of disease, notably cancer or infectious disease.
Public/Granted literature
- US20170198038A1 MULTISPECIFIC NKp46 BINDING PROTEINS Public/Granted day:2017-07-13
Information query